Health · 23 July 2026
GLP-1 weight loss drugs show 37% to 68% greater hair loss risk
A new study of about 50,000 people found that GLP-1 agonist drugs, like Ozempic and Wegovy, are linked to a higher risk of hair loss. Researchers at the University of Pennsylvania Health System discovered that GLP-1 drugs carried a 37% to 68% greater risk of alopecia when contrasted with other diabetes medications. The UK's MHRA has received hundreds of hair loss reports for these drugs.
Reported by Independent · How we write briefs